(Q42980546)

12 November 2017

Higher elimination rate of hepatitis C virus among women (English)

1 reference

12 November 2017

1 reference

1 reference

Yamakawa Y

1

1 reference

12 November 2017

Sata M

2

1 reference

12 November 2017

Suzuki H

3

1 reference

12 November 2017

Noguchi S

4

1 reference

12 November 2017

Tanikawa K

5

1 reference

12 November 2017

1 November 1996

1 reference

Journal of Viral Hepatitis

12 November 2017

1 reference

12 November 2017

3

1 reference

12 November 2017

6

1 reference

12 November 2017

317-321

1 reference

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00104.X

A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00104.X

Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00104.X

Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00104.X

Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00104.X

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00104.X

Second generation (RIBA) test in diagnosis of chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00104.X

Prevalence of chronic liver diseases and anti-HCV antibodies in different districts of Saga, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00104.X

Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00104.X

Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00104.X

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1996.TB00104.X

10.1111/J.1365-2893.1996.TB00104.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference